Roche Holding AG (ROP)
SIX
Real-time Data
07:00 AM
Day's Range
367.3052 wk Range
252.20Overview - ROP - Roche Holding AG
Key Statistics
Valuation
Enterprise Value
326.86B
P/E (Trailing)
‪24.75‬
P/E (Forward)
‪17.14‬
PEG Ratio
‪17.14‬
Price / Sales (TTM)
‪4.75‬
Price / Book
‪9.15‬
EV / EBITDA
‪13.64‬
Profitability
Profit Margin
‪19.60%‬
Operating Margin
‪36.20%‬
Return on Assets
‪13.50%‬
Return on Equity
‪38.10%‬
Ownership
Shares Outstanding
796.76M
Float
654.08M
Held by Insiders
‪0.00%‬
Held by Institutions
‪44.00%‬
Price stats
Beta
‪0.34‬
50-Day Avg
‪343.98‬
200-Day Avg
‪332.36‬
Dividends
Payout Ratio
‪63.93%‬
Frequency
Annual
Analyst Consensus
17 analysts
Average price target
‪CHF 370.31‬Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ROP - Roche Holding AG
Peers - ROP - Roche Holding AG
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on SIX.
- ROPSIXRoche Holding AG292.73BMarket Cap+29.11%52-week change23.54P/E (Trailing)‪19.60%‬Profit Margin
- LLYSIXEli Lilly and Company900.27BMarket Cap+44.06%52-week change41.32P/E (Trailing)‪33.52%‬Profit Margin
- JNJSIXJohnson & Johnson527.16BMarket Cap+21.06%52-week change29.18P/E (Trailing)‪21.48%‬Profit Margin
- MRKSIXMerck & Co., Inc.284.44BMarket Cap+32.03%52-week change32.58P/E (Trailing)‪13.58%‬Profit Margin
- NOVNEESIXNovartis AG248.37BMarket Cap+20.72%52-week change22.70P/E (Trailing)‪22.50%‬Profit Margin
- GILDSIXGilead Sciences Inc.145.04BMarket Cap+11.46%52-week change18.69P/E (Trailing)‪-10.63%‬Profit Margin
- PFESIXPfizer Inc.128.24BMarket Cap+8.04%52-week change36.29P/E (Trailing)‪6.80%‬Profit Margin
Profile Summary - ROP - Roche Holding AG
About
Roche Holding AG is a Swiss biopharmaceutical and diagnostics company headquartered in Basel, Switzerland. The company develops, manufactures, and markets innovative medicines and diagnostic solutions worldwide, with a strong focus on oncology therapies derived from its integration with Genentech. Its bestselling…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
